SlideShare a Scribd company logo
02.25.2016
Maria Shkrob, PhD
Project Manager,
Elsevier Professional Services
m.shkrob@elsevier.com
Cell-centered
Database for
Immunology and
Cancer
Research
| 2
Information avalanche
0
1000
2000
3000
4000
5000
6000
7000
201620112006200119961991198619811976197119661961195619511946192419191912
Number of publications covering cancer immunotherapy and immunooncology
*Data from PubMed
 Too much information: how
to survive
 Our approach -> Pathway
Studio
 Too much information
about cells in particular
 Examples of problems that
we help to solve
Today:
| 4
If only we knew what we know…
Amorphous information Structured information
Image Source: http://www.thesocialleader.com/wp-content/uploads/2011/03/paper-piles.jpg
Text mining: analyzing text to extract information that is useful for particular purposes
Text
mining
• Hard to deal with
• Hard to deal with algorithmically
• Not scalable
• Search
• Visualize
• Network analysis
• Scalable
• Compressed
20km
| 5
Manipulate facts not text to maximize your experience
with literature
Increased PARP activity has been
reported in HCC as compared with
healthy liver tissue
Quantitative Change
activity
positive
liver tissue
Regulation
Our results suggest that a natural
immune response mediated by γδ
T lymphocytes may contribute to
the immunosurveillance of
melanoma
24 M abstracts
3.5 M full texts
6.2 M relations
284 K entities
| 6
Explore the fact and it’s context
• Type of connection
• Sign
• intersect, combine and expand
Visualize
Summarize
| 7
Pathway Studio
Tools
Experiment analysis:
• Gene expression
• Proteomics
• Metabolomics
• NGS
Search Summarization
Navigation
Visualization
Knowledgebase
Manually
curated
pathways
Ontologies
Annotations
Biological
relations
extracted
from
literature
Variation
annotation
from public
sources
24M abstracts
3.5M full texts
6.2 M
relations
Pathway Studio Overview
| 8
Core databases
Disease and biomarkers-centered
Mammal
Chem
Effect
Disease
FX
Plant
Cell
Effect
Plant proteins, processes, pathways and
ontologies
Chemicals-centered
Standard database, protein-centered
Cell-centered
NEW
Finding cells and
facts about cells
| 10
Have you seen this cell?
full name
nickname
aka
formerly known as
scars
and
marks
for short
| 11
Epitope
From inconsistent names to standard names
Basic cell“Attribute”
CD4+ CD25+ regulatory T cell
T-lymphocyte leukocyte
T-cell leucocyte
hemopoetic
hemopoietic
haemopoetic
haemopoietic
hematopoetic
hematopoietic
haematopoetic
haematopoietic
regulatory
immunoregulatory
CD4+CD25+
CD25+FOXP3+
CD25+ CD4+
FOXP3+
| 12
From inconsistent names to standard names
Epitopes
“Attribute”
Basic cell
Standard
cell name
Image source: http://www.biooncology.com/images/therapeutic-targets/b-cell.png
Combination Frequency Standard name
Ep1+ Ep2- BC3 1000 BC4
Ep5+ BC6 2 BC6
Combination Frequency Standard name
Ep1+ Ep2- BC3 1000 BC4
Ep5+ BC6 100 EP5+ BC6
| 13
Adding cell processes to the mixture
proliferation of
death of
migration of human polarization
cytotoxicity
quantity
It allows to
• Have more cell processes in the database
• Assign cell processes to rare cells
• Quickly introduce changes if needed
Standard
cell
name
| 14
Recognizing cell processes in text
• Information about more specific cell types
• Doubles the number of cell processes compared to Gene Ontology +
EmTree
| 15
Cell-centered database
Proteins
Clinical
Parameters
Diseases
Small
molecules
Cells
| 16
protein regulates cell
cell expresses protein:
• surface
• secretion
Cells are connected to proteins
| 17
• chemicals naturally occurring
in human body
• pharmaceuticals
• biologically active peptides
• antibody drugs
• environmental chemicals,
• products of metabolism
Small molecules affect
cells
Cell produces small
molecule
Cells are connected to small molecules
| 18
State is
changed
Cells are
disease
biomakers
Quantity is
changed
Cells play
active
role in
diseases
Cells are connected to diseases and clinical
parameters
Cells affect
clinical
parameters
Cells are
somehow
related to
diseases
| 19
Database statistics
Objects
Cells 764
Cell Processes 8.7 K
Diseases 16 K
Clinical
Parameters
4.3 K
Proteins and
protein classes
148 K
Small
molecules
107 K
Relations
Binding 187 K
Biomarker 36 K
CellExpression 277 K
ChemicalReaction 54 K
ClinicalTrial 40 K
DirectRegulation 133 K
Expression 584 K
FunctionalAssociation 4 K
GeneticChange 248 K
MolSynthesis 39 K
MolTransport 14 K
PromoterBinding 32 K
ProtModification 52 K
QuantitativeChange 238 K
Regulation 3.6 M
StateChange 20 K
miRNA Effect 37 K
Over 830 K new relations
TOTAL:
284 K entities
6.2 M relations
Example 1:
Navigating literature
| 21
How melanoma cells suppress local immune
response?
Step 1
Disease Secretion Protein
What proteins are secreted from
melanoma cells?
| 22
Querying the database
| 23
Disease Secretion Protein
Step 2
What cells are negatively regulated
by these proteins?
Protein Regulation Cell
How melanoma cells suppress local immune
response?
Step 1
| 24
Step 3
Find cells that negatively regulate
melanoma
Cell Regulation Disease
Step 2
Step 1
Disease Secretion Protein
Protein Regulation Cell
How melanoma cells suppress local immune
response?
| 25
How melanoma cells suppress local immune
response?
Example 2
Analyze experiments:
• Gene expression
• Metabolomics
• Proteomics
• NGS
| 27
High grade astrocytoma survival
Background: 3-5% of glioblastoma patients survive longer than 3 years
What are the predictors of long survival?
High grade astrocytoma patient survival: brain tumor (GSE33331)
Comparison of surgical brain tumors of the long survival vs average survival
Increased Immune Gene Expression and Immune Cell Infiltration in High Grade Astrocytoma Distinguish Long from
Short-Term Survivors
Donson AM, Birks DK, Schittone SA, Kleinschmidt-DeMasters BK, Sun DY, Hemenway MF, Handler MH, Waziri AE, Wang M, Foreman NK.
J Immunol. 2012 Aug 15; 189(4): 1920–1927.
| 28
What is needed for long survival?
Survival
over 70
months
vs Functionally
annotate
genes
What processes
are they
involved in?
What pathways
are they
involved in?
Standard
survival
Results depend
on the quality
and granularity
of the database
| 29
Experiment analysis in Pathway Studio
| 30
Analysis of genes positively correlating with prognosis
Genes positively
correlated with
survival
Gene Set
Enrichment
Analysis using
Gene Ontology
Immune system
is involved, but
can we be more
specific?
| 31
Dig deeper into immune component
Gene Ontology
Mammal
ChemEffect
DIseaseFX
Mammal
ChemEffect
DIseaseFX+cells
28 55 63
T cells
B cells
Leukocytes
Lymphocytes
Neutrofils
+
Macrophages
Dendritic cells
Monocytes
T helpers
+
Th1 cells
Th2 cells
Th17 cells
Tregs
CD8+ T cells
immune
processes
in top 100
immune
cells
in top 100
| 32
Additional cell processes – additional results
red – significantly up-regulated genes
| 33
Does this new information make sense?
Known connections
between immune cells
identified in analysis
and brain tumors
| 34
• New database is focused on cell-centered
facts
• It adds over 800K new relations to Pathway
Studio Knowledgebase which now contains
6.2 M relations
• New data can be used to answer complex
biological questions and analyze
experiments
Summary
Thank you

More Related Content

What's hot

NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
IJTRET-International Journal of Trendy Research in Engineering and Technology
 
Literature Management for Pharmacovigilance: Outsource or in-house solution? ...
Literature Management for Pharmacovigilance: Outsource or in-house solution? ...Literature Management for Pharmacovigilance: Outsource or in-house solution? ...
Literature Management for Pharmacovigilance: Outsource or in-house solution? ...
Ann-Marie Roche
 
Searching literature databases for post authorisation safety studies (pass)
Searching literature databases for post authorisation safety studies (pass)Searching literature databases for post authorisation safety studies (pass)
Searching literature databases for post authorisation safety studies (pass)
Ann-Marie Roche
 
Keynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceKeynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidence
Richard Boyce, PhD
 
Qiu_CV_Feb12_2017
Qiu_CV_Feb12_2017Qiu_CV_Feb12_2017
Qiu_CV_Feb12_2017
Weiliang Qiu
 
Initial progress on the journey toward an open source potential drug-drug int...
Initial progress on the journey toward an open source potential drug-drug int...Initial progress on the journey toward an open source potential drug-drug int...
Initial progress on the journey toward an open source potential drug-drug int...
Richard Boyce, PhD
 
Pathway studiosymposium lorenzi
Pathway studiosymposium lorenziPathway studiosymposium lorenzi
Pathway studiosymposium lorenzi
Ann-Marie Roche
 
Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...
Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...
Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...
Richard Boyce, PhD
 
Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0
Ann-Marie Roche
 
Literature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solutionLiterature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solution
Julio dos Anjos
 
Turning Big Data into Precision Medicine
Turning Big Data into Precision MedicineTurning Big Data into Precision Medicine
Turning Big Data into Precision Medicine
Matthieu Schapranow
 
Drug repurposing
Drug repurposingDrug repurposing
Drug repurposing
Aaqib Naseer
 
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
Dexter Hadley
 
Drug Repurposing- Amazing Opportunity
Drug Repurposing- Amazing Opportunity Drug Repurposing- Amazing Opportunity
Drug Repurposing- Amazing Opportunity
Dr Seema Kohli
 
BioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryBioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug Discovery
Josef Scheiber
 
BCATSfinal
BCATSfinalBCATSfinal
BCATSfinal
Shruti Marwaha
 
zhe_CRI2015_drug_v2
zhe_CRI2015_drug_v2zhe_CRI2015_drug_v2
zhe_CRI2015_drug_v2
Zhe (Henry) He
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
Warren Kibbe
 
The story of personalized medicine
The story of personalized medicineThe story of personalized medicine
The story of personalized medicine
Seth Taylor
 
Alopecia Areata Research Summit Summary
Alopecia Areata Research Summit SummaryAlopecia Areata Research Summit Summary
Alopecia Areata Research Summit Summary
National Alopecia Areata Foundation
 

What's hot (20)

NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
NETWORK OF DISEASES AND ITS ENDOWMENT TOWARDS DISEASE
 
Literature Management for Pharmacovigilance: Outsource or in-house solution? ...
Literature Management for Pharmacovigilance: Outsource or in-house solution? ...Literature Management for Pharmacovigilance: Outsource or in-house solution? ...
Literature Management for Pharmacovigilance: Outsource or in-house solution? ...
 
Searching literature databases for post authorisation safety studies (pass)
Searching literature databases for post authorisation safety studies (pass)Searching literature databases for post authorisation safety studies (pass)
Searching literature databases for post authorisation safety studies (pass)
 
Keynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidenceKeynote malone-clinical-relevance-of-ddi-evidence
Keynote malone-clinical-relevance-of-ddi-evidence
 
Qiu_CV_Feb12_2017
Qiu_CV_Feb12_2017Qiu_CV_Feb12_2017
Qiu_CV_Feb12_2017
 
Initial progress on the journey toward an open source potential drug-drug int...
Initial progress on the journey toward an open source potential drug-drug int...Initial progress on the journey toward an open source potential drug-drug int...
Initial progress on the journey toward an open source potential drug-drug int...
 
Pathway studiosymposium lorenzi
Pathway studiosymposium lorenziPathway studiosymposium lorenzi
Pathway studiosymposium lorenzi
 
Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...
Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...
Piloting a Comprehensive Knowledge Base for Pharmacovigilance Using Standardi...
 
Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0
 
Literature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solutionLiterature monitoring for pharmacovigilance – outsourcing or in house solution
Literature monitoring for pharmacovigilance – outsourcing or in house solution
 
Turning Big Data into Precision Medicine
Turning Big Data into Precision MedicineTurning Big Data into Precision Medicine
Turning Big Data into Precision Medicine
 
Drug repurposing
Drug repurposingDrug repurposing
Drug repurposing
 
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
From Bits to Bedside: Translating Big Data into Precision Medicine and Digita...
 
Drug Repurposing- Amazing Opportunity
Drug Repurposing- Amazing Opportunity Drug Repurposing- Amazing Opportunity
Drug Repurposing- Amazing Opportunity
 
BioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug DiscoveryBioVariance - Pediatric Pharmacogenomics in Drug Discovery
BioVariance - Pediatric Pharmacogenomics in Drug Discovery
 
BCATSfinal
BCATSfinalBCATSfinal
BCATSfinal
 
zhe_CRI2015_drug_v2
zhe_CRI2015_drug_v2zhe_CRI2015_drug_v2
zhe_CRI2015_drug_v2
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
 
The story of personalized medicine
The story of personalized medicineThe story of personalized medicine
The story of personalized medicine
 
Alopecia Areata Research Summit Summary
Alopecia Areata Research Summit SummaryAlopecia Areata Research Summit Summary
Alopecia Areata Research Summit Summary
 

Similar to Cell centered database for immunology and cancer research feb252016

Cancer immunity webinar april 29
Cancer immunity webinar april 29Cancer immunity webinar april 29
Cancer immunity webinar april 29
Ann-Marie Roche
 
2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester
Alain van Gool
 
2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem
Alain van Gool
 
2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
Alain van Gool
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
Warren Kibbe
 
Next Gen Sequencing and Associated Big Data / AI problem
Next Gen Sequencing and Associated Big Data / AI problemNext Gen Sequencing and Associated Big Data / AI problem
Next Gen Sequencing and Associated Big Data / AI problem
Subhendu Dey
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017
Warren Kibbe
 
Nw biotech fundamentals day 1 session 5 life sciences
Nw biotech fundamentals day 1 session 5   life sciencesNw biotech fundamentals day 1 session 5   life sciences
Nw biotech fundamentals day 1 session 5 life sciences
Nicholas Weston Lawyers
 
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
Warren Kibbe
 
Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...
Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...
Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...
NHS England
 
ACS Spring 2016 Combining semantic triple stores across knowledge domains
ACS Spring 2016 Combining semantic triple stores across knowledge domainsACS Spring 2016 Combining semantic triple stores across knowledge domains
ACS Spring 2016 Combining semantic triple stores across knowledge domains
Matthew Clark
 
Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014 Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014
Warren Kibbe
 
Zen and the Art of Data Science Maintenance
Zen and the Art of Data Science MaintenanceZen and the Art of Data Science Maintenance
Zen and the Art of Data Science Maintenance
Elsevier
 
Big Data Analytics in the Health Domain
Big Data Analytics in the Health DomainBig Data Analytics in the Health Domain
Big Data Analytics in the Health Domain
BigData_Europe
 
"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery
Pete Shuster
 
Dalton
DaltonDalton
Dalton presentation
Dalton presentationDalton presentation
Molecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdfMolecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdf
sabyabby
 
CancerBioinformatics_DataTypesResources_012215.pptx
CancerBioinformatics_DataTypesResources_012215.pptxCancerBioinformatics_DataTypesResources_012215.pptx
CancerBioinformatics_DataTypesResources_012215.pptx
QiZhi2
 
16
1616

Similar to Cell centered database for immunology and cancer research feb252016 (20)

Cancer immunity webinar april 29
Cancer immunity webinar april 29Cancer immunity webinar april 29
Cancer immunity webinar april 29
 
2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester2015 2-23 Oxford Global 2015 Manchester
2015 2-23 Oxford Global 2015 Manchester
 
2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem
 
2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
 
Next Gen Sequencing and Associated Big Data / AI problem
Next Gen Sequencing and Associated Big Data / AI problemNext Gen Sequencing and Associated Big Data / AI problem
Next Gen Sequencing and Associated Big Data / AI problem
 
Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017Precision oncology ncabr kibbe oct 2017
Precision oncology ncabr kibbe oct 2017
 
Nw biotech fundamentals day 1 session 5 life sciences
Nw biotech fundamentals day 1 session 5   life sciencesNw biotech fundamentals day 1 session 5   life sciences
Nw biotech fundamentals day 1 session 5 life sciences
 
ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014ICBO 2014, October 8, 2014
ICBO 2014, October 8, 2014
 
Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...
Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...
Data in genomics: Dr Richard Scott, Clinical Lead for Rare Disease, 100,000 G...
 
ACS Spring 2016 Combining semantic triple stores across knowledge domains
ACS Spring 2016 Combining semantic triple stores across knowledge domainsACS Spring 2016 Combining semantic triple stores across knowledge domains
ACS Spring 2016 Combining semantic triple stores across knowledge domains
 
Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014 Federal Research & Development for the Florida system Sept 2014
Federal Research & Development for the Florida system Sept 2014
 
Zen and the Art of Data Science Maintenance
Zen and the Art of Data Science MaintenanceZen and the Art of Data Science Maintenance
Zen and the Art of Data Science Maintenance
 
Big Data Analytics in the Health Domain
Big Data Analytics in the Health DomainBig Data Analytics in the Health Domain
Big Data Analytics in the Health Domain
 
"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery"Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug Discovery
 
Dalton
DaltonDalton
Dalton
 
Dalton presentation
Dalton presentationDalton presentation
Dalton presentation
 
Molecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdfMolecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdf
 
CancerBioinformatics_DataTypesResources_012215.pptx
CancerBioinformatics_DataTypesResources_012215.pptxCancerBioinformatics_DataTypesResources_012215.pptx
CancerBioinformatics_DataTypesResources_012215.pptx
 
16
1616
16
 

More from Ann-Marie Roche

How predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinarHow predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinar
Ann-Marie Roche
 
Webinar: New RMC - Your lead_optimization Solution June082017
Webinar: New RMC - Your lead_optimization Solution June082017Webinar: New RMC - Your lead_optimization Solution June082017
Webinar: New RMC - Your lead_optimization Solution June082017
Ann-Marie Roche
 
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor TariOil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari
Ann-Marie Roche
 
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob ForknerOil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner
Ann-Marie Roche
 
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander HoubenOil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben
Ann-Marie Roche
 
Embase for pharmacovigilance: Search and validation March 22 2017
Embase for pharmacovigilance: Search and validation March 22 2017Embase for pharmacovigilance: Search and validation March 22 2017
Embase for pharmacovigilance: Search and validation March 22 2017
Ann-Marie Roche
 
Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016
Ann-Marie Roche
 
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
Ann-Marie Roche
 
Eac webinar 09.21.2016
Eac webinar 09.21.2016Eac webinar 09.21.2016
Eac webinar 09.21.2016
Ann-Marie Roche
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
Ann-Marie Roche
 
Knovel lss webinar
Knovel lss webinarKnovel lss webinar
Knovel lss webinar
Ann-Marie Roche
 
Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_
Ann-Marie Roche
 
Julie glanville embase sunrise seminar may 2016
Julie glanville embase sunrise seminar may 2016Julie glanville embase sunrise seminar may 2016
Julie glanville embase sunrise seminar may 2016
Ann-Marie Roche
 
Ian crowlesmith embase retrospective mla 2016
Ian crowlesmith embase retrospective mla 2016Ian crowlesmith embase retrospective mla 2016
Ian crowlesmith embase retrospective mla 2016
Ann-Marie Roche
 
Ivan krstic embase update mla 2016
Ivan krstic embase update mla 2016Ivan krstic embase update mla 2016
Ivan krstic embase update mla 2016
Ann-Marie Roche
 
Kp bloch psm preparedness final rev
Kp bloch psm preparedness final revKp bloch psm preparedness final rev
Kp bloch psm preparedness final rev
Ann-Marie Roche
 
Mobilizing informational resources webinar
Mobilizing informational resources   webinarMobilizing informational resources   webinar
Mobilizing informational resources webinar
Ann-Marie Roche
 
Searching socialmediaforadverseevents
Searching socialmediaforadverseeventsSearching socialmediaforadverseevents
Searching socialmediaforadverseevents
Ann-Marie Roche
 
Elsevier in the classroom training module i 04-14-16
Elsevier in the classroom   training module i  04-14-16Elsevier in the classroom   training module i  04-14-16
Elsevier in the classroom training module i 04-14-16
Ann-Marie Roche
 
Rx inclassroom 190416
Rx inclassroom 190416Rx inclassroom 190416
Rx inclassroom 190416
Ann-Marie Roche
 

More from Ann-Marie Roche (20)

How predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinarHow predictive models help Medicinal Chemists design better drugs_webinar
How predictive models help Medicinal Chemists design better drugs_webinar
 
Webinar: New RMC - Your lead_optimization Solution June082017
Webinar: New RMC - Your lead_optimization Solution June082017Webinar: New RMC - Your lead_optimization Solution June082017
Webinar: New RMC - Your lead_optimization Solution June082017
 
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor TariOil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari
 
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob ForknerOil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner
 
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander HoubenOil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben
 
Embase for pharmacovigilance: Search and validation March 22 2017
Embase for pharmacovigilance: Search and validation March 22 2017Embase for pharmacovigilance: Search and validation March 22 2017
Embase for pharmacovigilance: Search and validation March 22 2017
 
Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016Finding the right medical device information in embase 11 2016
Finding the right medical device information in embase 11 2016
 
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
 
Eac webinar 09.21.2016
Eac webinar 09.21.2016Eac webinar 09.21.2016
Eac webinar 09.21.2016
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
 
Knovel lss webinar
Knovel lss webinarKnovel lss webinar
Knovel lss webinar
 
Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_
 
Julie glanville embase sunrise seminar may 2016
Julie glanville embase sunrise seminar may 2016Julie glanville embase sunrise seminar may 2016
Julie glanville embase sunrise seminar may 2016
 
Ian crowlesmith embase retrospective mla 2016
Ian crowlesmith embase retrospective mla 2016Ian crowlesmith embase retrospective mla 2016
Ian crowlesmith embase retrospective mla 2016
 
Ivan krstic embase update mla 2016
Ivan krstic embase update mla 2016Ivan krstic embase update mla 2016
Ivan krstic embase update mla 2016
 
Kp bloch psm preparedness final rev
Kp bloch psm preparedness final revKp bloch psm preparedness final rev
Kp bloch psm preparedness final rev
 
Mobilizing informational resources webinar
Mobilizing informational resources   webinarMobilizing informational resources   webinar
Mobilizing informational resources webinar
 
Searching socialmediaforadverseevents
Searching socialmediaforadverseeventsSearching socialmediaforadverseevents
Searching socialmediaforadverseevents
 
Elsevier in the classroom training module i 04-14-16
Elsevier in the classroom   training module i  04-14-16Elsevier in the classroom   training module i  04-14-16
Elsevier in the classroom training module i 04-14-16
 
Rx inclassroom 190416
Rx inclassroom 190416Rx inclassroom 190416
Rx inclassroom 190416
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 

Cell centered database for immunology and cancer research feb252016

  • 1. 02.25.2016 Maria Shkrob, PhD Project Manager, Elsevier Professional Services m.shkrob@elsevier.com Cell-centered Database for Immunology and Cancer Research
  • 3.  Too much information: how to survive  Our approach -> Pathway Studio  Too much information about cells in particular  Examples of problems that we help to solve Today:
  • 4. | 4 If only we knew what we know… Amorphous information Structured information Image Source: http://www.thesocialleader.com/wp-content/uploads/2011/03/paper-piles.jpg Text mining: analyzing text to extract information that is useful for particular purposes Text mining • Hard to deal with • Hard to deal with algorithmically • Not scalable • Search • Visualize • Network analysis • Scalable • Compressed 20km
  • 5. | 5 Manipulate facts not text to maximize your experience with literature Increased PARP activity has been reported in HCC as compared with healthy liver tissue Quantitative Change activity positive liver tissue Regulation Our results suggest that a natural immune response mediated by γδ T lymphocytes may contribute to the immunosurveillance of melanoma 24 M abstracts 3.5 M full texts 6.2 M relations 284 K entities
  • 6. | 6 Explore the fact and it’s context • Type of connection • Sign • intersect, combine and expand Visualize Summarize
  • 7. | 7 Pathway Studio Tools Experiment analysis: • Gene expression • Proteomics • Metabolomics • NGS Search Summarization Navigation Visualization Knowledgebase Manually curated pathways Ontologies Annotations Biological relations extracted from literature Variation annotation from public sources 24M abstracts 3.5M full texts 6.2 M relations Pathway Studio Overview
  • 8. | 8 Core databases Disease and biomarkers-centered Mammal Chem Effect Disease FX Plant Cell Effect Plant proteins, processes, pathways and ontologies Chemicals-centered Standard database, protein-centered Cell-centered NEW
  • 10. | 10 Have you seen this cell? full name nickname aka formerly known as scars and marks for short
  • 11. | 11 Epitope From inconsistent names to standard names Basic cell“Attribute” CD4+ CD25+ regulatory T cell T-lymphocyte leukocyte T-cell leucocyte hemopoetic hemopoietic haemopoetic haemopoietic hematopoetic hematopoietic haematopoetic haematopoietic regulatory immunoregulatory CD4+CD25+ CD25+FOXP3+ CD25+ CD4+ FOXP3+
  • 12. | 12 From inconsistent names to standard names Epitopes “Attribute” Basic cell Standard cell name Image source: http://www.biooncology.com/images/therapeutic-targets/b-cell.png Combination Frequency Standard name Ep1+ Ep2- BC3 1000 BC4 Ep5+ BC6 2 BC6 Combination Frequency Standard name Ep1+ Ep2- BC3 1000 BC4 Ep5+ BC6 100 EP5+ BC6
  • 13. | 13 Adding cell processes to the mixture proliferation of death of migration of human polarization cytotoxicity quantity It allows to • Have more cell processes in the database • Assign cell processes to rare cells • Quickly introduce changes if needed Standard cell name
  • 14. | 14 Recognizing cell processes in text • Information about more specific cell types • Doubles the number of cell processes compared to Gene Ontology + EmTree
  • 16. | 16 protein regulates cell cell expresses protein: • surface • secretion Cells are connected to proteins
  • 17. | 17 • chemicals naturally occurring in human body • pharmaceuticals • biologically active peptides • antibody drugs • environmental chemicals, • products of metabolism Small molecules affect cells Cell produces small molecule Cells are connected to small molecules
  • 18. | 18 State is changed Cells are disease biomakers Quantity is changed Cells play active role in diseases Cells are connected to diseases and clinical parameters Cells affect clinical parameters Cells are somehow related to diseases
  • 19. | 19 Database statistics Objects Cells 764 Cell Processes 8.7 K Diseases 16 K Clinical Parameters 4.3 K Proteins and protein classes 148 K Small molecules 107 K Relations Binding 187 K Biomarker 36 K CellExpression 277 K ChemicalReaction 54 K ClinicalTrial 40 K DirectRegulation 133 K Expression 584 K FunctionalAssociation 4 K GeneticChange 248 K MolSynthesis 39 K MolTransport 14 K PromoterBinding 32 K ProtModification 52 K QuantitativeChange 238 K Regulation 3.6 M StateChange 20 K miRNA Effect 37 K Over 830 K new relations TOTAL: 284 K entities 6.2 M relations
  • 21. | 21 How melanoma cells suppress local immune response? Step 1 Disease Secretion Protein What proteins are secreted from melanoma cells?
  • 22. | 22 Querying the database
  • 23. | 23 Disease Secretion Protein Step 2 What cells are negatively regulated by these proteins? Protein Regulation Cell How melanoma cells suppress local immune response? Step 1
  • 24. | 24 Step 3 Find cells that negatively regulate melanoma Cell Regulation Disease Step 2 Step 1 Disease Secretion Protein Protein Regulation Cell How melanoma cells suppress local immune response?
  • 25. | 25 How melanoma cells suppress local immune response?
  • 26. Example 2 Analyze experiments: • Gene expression • Metabolomics • Proteomics • NGS
  • 27. | 27 High grade astrocytoma survival Background: 3-5% of glioblastoma patients survive longer than 3 years What are the predictors of long survival? High grade astrocytoma patient survival: brain tumor (GSE33331) Comparison of surgical brain tumors of the long survival vs average survival Increased Immune Gene Expression and Immune Cell Infiltration in High Grade Astrocytoma Distinguish Long from Short-Term Survivors Donson AM, Birks DK, Schittone SA, Kleinschmidt-DeMasters BK, Sun DY, Hemenway MF, Handler MH, Waziri AE, Wang M, Foreman NK. J Immunol. 2012 Aug 15; 189(4): 1920–1927.
  • 28. | 28 What is needed for long survival? Survival over 70 months vs Functionally annotate genes What processes are they involved in? What pathways are they involved in? Standard survival Results depend on the quality and granularity of the database
  • 29. | 29 Experiment analysis in Pathway Studio
  • 30. | 30 Analysis of genes positively correlating with prognosis Genes positively correlated with survival Gene Set Enrichment Analysis using Gene Ontology Immune system is involved, but can we be more specific?
  • 31. | 31 Dig deeper into immune component Gene Ontology Mammal ChemEffect DIseaseFX Mammal ChemEffect DIseaseFX+cells 28 55 63 T cells B cells Leukocytes Lymphocytes Neutrofils + Macrophages Dendritic cells Monocytes T helpers + Th1 cells Th2 cells Th17 cells Tregs CD8+ T cells immune processes in top 100 immune cells in top 100
  • 32. | 32 Additional cell processes – additional results red – significantly up-regulated genes
  • 33. | 33 Does this new information make sense? Known connections between immune cells identified in analysis and brain tumors
  • 34. | 34 • New database is focused on cell-centered facts • It adds over 800K new relations to Pathway Studio Knowledgebase which now contains 6.2 M relations • New data can be used to answer complex biological questions and analyze experiments Summary